Skip to main content
Funded Studies

Protective Effect of Immune Gene Subtype in Parkinson’s Disease

Study Rationale: Our genetic studies of Parkinson’s disease (PD) have found a protective effect of an immune gene called HLA-DR, specifically the presence of the HLA-DRB1*04 subtype. We found that HLA-DRB1*04 binds specifically to a part of alpha-synuclein, the protein enriched in Lewy body aggregates seen in PD brains. We hypothesize that these alpha-synuclein fragments, when bound to HLA- DRB1*04, stimulate immune cells that in turn help clear Lewy body aggregates or prevent their formation. In this study, we investigate how this happens and why individuals with the HLA-DRB1*04 gene are protected from PD. The findings could lead to new immune-based therapies.

Hypothesis: We hypothesize that DRB1*04 binds to a critical part of alpha-synuclein and that this association drives an effective immune response that allows fewer alpha-synuclein aggregates and Lewy bodies to form in the brain.

Study Design: Our immunogenetic analyses will examine 30,000 post-mortem brain samples to examine the HLA-DR subtypes associations in PD, determine whether the age of onset of PD symptoms is associated with DRB1*04 and analyze the association of DRB1*04 with Lewy bodies in PD brain samples and Lewy body disease samples. Our functional immune studies will identify the alpha-synuclein fragments that bind to DRB1*04 and use these fragments to isolate, analyze and compare the alpha-synuclein reactive immune T cells from PD patients and controls.

Impact on Diagnosis/Treatment of Parkinson’s disease: Knowledge of the mechanism of how DRB1*04 mediates protection against PD could be used to slow or stop PD progression. Furthermore, determining the immune correlates of PD protection could be used as a therapeutic biomarker.

Next Steps for Development: Our findings could pave the way for immunotherapies in which alpha-synuclein reactive immune cells or antibodies are us


  • Emmanuel Mignot

    Palo Alto, CA United States

  • Ziv Gan-Or, MD, PhD

    Montreal QC Canada

Discover More Grants

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.